Nomogram to predict contralateral breast cancer risk in breast cancer survivors: A SEER-based study.

Medicine (Baltimore) · 2021 · PMC8601336 · PMID 34797281

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

[ 20 ] If the follow-up period is short or the competing risk is low, the difference between the traditional survival analysis method and the competing risk method may not be significant.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.